Triethylamine → HCID 86594555, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:19]=[CH:18][C:17]([C:20]3[C:24]([NH:25][C@H:26]([C:31]([OH:33])=O)[CH2:27][CH:28]([CH3:30])[CH3:29])=[CH:23][O:22][N:21]=3)=[CH:16][CH:15]=2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.[NH2:35][CH2:36][C:37]#[N:38].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)CC)C>CN(C=O)C>[C:36]([CH2:37][NH:38][C:31](=[O:33])[C@H:26]([CH2:27][CH:28]([CH3:30])[CH3:29])[NH:25][C:24]1[C:20]([C:17]2[CH:16]=[CH:15][C:14]([N:11]3[CH2:12][CH2:13][N:8]([C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[CH2:9][CH2:10]3)=[CH:19][CH:18]=2)=[N:21][O:22][CH:23]=1)#[N:35]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a 0° C. solution of N-(3-{4-[4-(tert-butoxycarbonyl)piperazin-1-yl]phenyl}isoxazol-4-yl)leucine (46 mg, 0.10 mmol), aminoacetonitrile hydrochloride (21 mg, 0.23 mmol) and HATU. (140 mg, 0.36 mmol) in DMF (3 mL) was added triethylamine (0.06 mL, 0.43 mmol). The solution was stirred 1 h, then partitioned between ether and pH 3.5 phosphate buffer. The organic phase was washed with brine and concentrated. Purification by flash chromatography (40% to 60% ethyl acetate/hexanes) gave 15.5 mg of N1-(cyanomethyl)-N2-[3-(4-[4-(tert-butoxycarbonyl)piperazin-1-yl]phenyl)isoxazol-4-yl]leucinamide.
Workup
- customTo a 0° C.
- custompartitioned between ether and pH 3.5 phosphate buffer
- washThe organic phase was washed with brine
- concentrationconcentrated
- customPurification by flash chromatography (40% to 60% ethyl acetate/hexanes)
Sources & evidence
- ORD record
- ord-70878358caae40ba85671c9e3a993b5a
- Source dataset
- uspto-grants-2006_03
- Patent number
- US07012075B2
Reaction notes
Loading…